Europe dipeptidyl peptidase 4 (DPP-4) inhibitors market is anticipated to grow significantly at a CAGR of 3.3% over the forecast period (2020-2026). As per the International Diabetes Foundation IDF, around 59.3 million adults in the age range of 20-79 years are living with diabetes in the region in 2019. It represents around 8.9% of the regional […]
